Hemapoeitic differentiation and therapeutic potential of uniparent parthenogenetic embryonal stem cells
- 作者: Lopatina T.
- 期: 卷 2, 编号 2 (2007)
- 页面: 14-15
- 栏目: Cell transplant
- ##submission.dateSubmitted##: 10.02.2023
- ##submission.dateAccepted##: 10.02.2023
- ##submission.datePublished##: 14.02.2023
- URL: https://genescells.ru/2313-1829/article/view/217688
- ID: 217688
如何引用文章
全文:
![受限制的访问](https://genescells.ru/lib/pkp/templates/images/icons/text_lock.png)
参考
- Mann J.R., Gadi I., Нarbison M.L., Abbondanzo S.J. Androgenetic mouse embryonic stem cells are pluripotent and cause skeletal defects in chimeras: implications for genetic imprinting. Cell 1990; 62(2): 251-60.
- Stevens L.C., Varnum D.S., Eicher E.M.. Viable chimaeras produced from normal and parthenogenetic mouse embryos. Nature 1977; 269: 515-7.
- Surani M.A., Вarton S.C., Kaufman M.Н. Development to term of chimaeras between diploid parthenogenetic and fertilised embryos. Nature 1977; 270: 601-3.
- Kennedy M., Keller G.M. Нematopoietic commitment of ES cells in culture. Methods Enzymol. 2003; 365: 39-59.
补充文件
![](/img/style/loading.gif)